[Intravenous substitution with immunoglobulins]
- PMID: 1949811
[Intravenous substitution with immunoglobulins]
Abstract
A survey of clinical data shows that substitution with intravenous immunoglobulins constitutes an essential further step in the therapy of patients with immunodeficiencies: patients with primary and some secondary immunodeficiencies clearly benefit from intravenous immunoglobulin substitution. Some other diseases including idiopathic thrombocytopenic purpura and the Kawasaki syndrome also constitute indications for this kind of treatment. In other cases (infections in newborn preterm infants, children with AIDS, chronic inflammatory demyelinizing polyneuropathies and the Guillain-Barré syndrome and children with refractory seizures) there are reasons to believe that intravenous immunoglobulin therapy can be of benefit, although bigger controlled studies are still necessary to allow definitive conclusions to be reached. Further attempts will have to be made to improve understanding of the mode of action of intravenously administered immunoglobulin.
Similar articles
-
Intravenous immunoglobulin: new clinical applications.Ann Allergy. 1988 Feb;60(2):89-94. Ann Allergy. 1988. PMID: 2829663 Review.
-
[New indications for gamma globulins].An Esp Pediatr. 1992 Jun;36 Suppl 48:135-8. An Esp Pediatr. 1992. PMID: 1379010 Spanish.
-
Applications of intravenous immunoglobulin.Malays J Pathol. 1990 Jun;12(1):1-10. Malays J Pathol. 1990. PMID: 2090883
-
Intravenous immunoglobulin, immunodeficiency syndromes and idiopathic thrombocytopenic purpura. Proceedings of a workshop. Edinburgh, Scotland, 4 and 5 December 1986.J Infect. 1987 Jul;15 Suppl 1:1-65. J Infect. 1987. PMID: 3117895 No abstract available.
-
[Use of intravenous immunoglobulins in pediatrics].Pediatr Med Chir. 1991 Mar-Apr;13(2):117-25. Pediatr Med Chir. 1991. PMID: 1896376 Review. Italian.